Courtesy of Carl Elliott via Twitter, I’ve recently read Dr. Lieberman’s latest post on Psychiatric News. It’s called – believe it or not – Time to Re-Engage With Pharma? dated August 1, 2013. And it’s classic Dr. Lieberman sleight of hand. His opening statement, for instance, reads: “Drug companies aren’t held in high esteem by… Continue Reading
Are The Second Generation Neuroleptics Good For the Brain?
There’s an editorial by Henry Nasrallah, MD, in last month’s edition of Current Psychiatry. Dr. Nasrallah is the journal’s editor-in-chief. The title of the article is Haloperidol clearly is neurotoxic. Should it be banned? Haloperidol is marketed under the brand name Haldol, but its patent has long expired, and a generic version is available and inexpensive…. Continue Reading
Medical Model vs. Psychosocial/Behavioral Model
BACKGROUND Obviously there are many points of contention between mainstream biological psychiatrists on the one hand, and those of us who condemn this system as spurious and destructive. Much of what I’ve written on this website over the past four years has been an elucidation of these differences. Today I would like to focus on… Continue Reading
Another Critique Of The Good Dr. Lieberman
Duncan Double, MD, one of the founding members of the UK’s Critical Psychiatry Network, has written a compelling and insightful critique of Dr. Lieberman’s most recent article. Dr. Double’s article is titled Is APA prepared to engage with critical psychiatry? Definitely worth a read.
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 146
- Next Page »